Deferoxamine Injection Shortage
Last Updated: May 20, 2024
Status: Current
Products Affected - Description
-
- Desferal injection, Novartis, 500 mg, vial, 4 count, NDC 00078-0467-91
Reason for the Shortage
-
- Apotex has deferoxamine injection available.
- Fresenius Kabi has deferoxamine injection available.
- Pfizer has deferoxamine injection available.
- Novartis did not provide a reason for the shortage.
Available Products
-
- Deferoxamine injection, Apotex, 2 gram, vial, 4 count, NDC 60505-6237-06
- Deferoxamine injection, Apotex, 500 mg, vial, 4 count, NDC 60505-6236-06
- Deferoxamine injection, Fresenius Kabi, 2 gram, vial, 1 count, NDC 63323-0599-30
- Deferoxamine injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0597-10
- Deferoxamine injection, Pfizer, 2 gram, vial, 4 count, NDC 00409-2337-25
Estimated Resupply Dates
-
- Novartis has Desferal 500 mg vials on back order and the company estimates a release date of early-June 2024.
Updated
Updated May 20, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 7, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.